Catalyst Pharmaceuticals Inc
NASDAQ:CPRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Catalyst Pharmaceuticals Inc
NASDAQ:CPRX
|
US |
|
H
|
HB Technology Co Ltd
KOSDAQ:078150
|
KR |
|
Tower Resources PLC
F:ULF1
|
UK |
|
L
|
Life Storage Inc
F:SOV
|
US |
|
Genting Singapore Ltd
F:36T
|
SG |
|
M
|
Mitsubishi Logistics Corp
TSE:9301
|
JP |
|
C
|
Cronos Group Inc
XBER:7CI
|
CA |
|
F
|
FirstEnergy Corp
F:FE7
|
US |
|
M
|
MNtech Co Ltd
KOSDAQ:095500
|
KR |
|
Kyoritsu Maintenance Co Ltd
TSE:9616
|
JP |
|
Cadence Design Systems Inc
NASDAQ:CDNS
|
US |
|
Plato Gold Corp
F:4Y7
|
CA |
|
U
|
US BioTec Inc
AMEX:USBC
|
US |
|
Akzo Nobel NV
AEX:AKZA
|
NL |
|
Southern Co
NYSE:SO
|
US |
|
F
|
Forte Minerals Corp
CNSX:CUAU
|
CA |
|
Fobi AI Inc
XTSX:FOBI
|
CA |
|
Bank KB Bukopin Tbk PT
IDX:BBKP
|
ID |
|
Rio Tinto Ltd
ASX:RIO
|
AU |
|
Wall Street Finance Ltd
BSE:511147
|
IN |
|
U
|
Urgent.ly Inc
NASDAQ:ULY
|
US |
|
Carlo Gavazzi Holding AG
SIX:GAV
|
CH |
|
Coliseum Acquisition Corp
NASDAQ:MITA
|
US |
|
Thales SA
PAR:HO
|
FR |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CPRX's stock price target?
Not Available
CPRX does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Catalyst Pharmaceuticals Inc?
Projected CAGR
7%
The compound annual growth rate for Revenue over the next 8 years is 7%.
What is the Gross Profit forecast for Catalyst Pharmaceuticals Inc?
Projected CAGR
7%
The compound annual growth rate for Gross Profit over the next 8 years is 7%.
What is the Operating Income forecast for Catalyst Pharmaceuticals Inc?
Projected CAGR
9%
The compound annual growth rate for Operating Income over the next 8 years is 9%.
What is the Pre-Tax Income forecast for Catalyst Pharmaceuticals Inc?
Projected CAGR
9%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 9%.
What is the Net Income forecast for Catalyst Pharmaceuticals Inc?
Projected CAGR
26%
The compound annual growth rate for Net Income over the next 5 years is 26%.
